Literature DB >> 10318769

Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland.

A D Metcalfe1, A Gilmore, T Klinowska, J Oliver, A J Valentijn, R Brown, A Ross, G MacGregor, J A Hickman, C H Streuli.   

Abstract

Epithelial cells within the mammary gland undergo developmental programmes of proliferation and apoptosis during the pregnancy cycle. After weaning, secretory epithelial cells are removed by apoptosis. To determine whether members of the Bcl-2 gene family could be involved in regulating this process, we have examined whether changes in their expression occur during this developmental apoptotic program in vivo. Bax and Bcl-x were evenly expressed throughout development. However, expression of Bak and Bad was increased during late pregnancy and lactation, and the proteins were present during the time of maximal apoptotic involution. Thereafter, their levels declined. In contrast, Bcl-w was expressed in pregnancy and lactation but was downregulated at the onset of apoptosis. Bcl-2 was not detected in lactating or early involuting mammary gland. Thus, the pro-apoptotic proteins Bax, Bak and Bad, as well as the death-suppressors Bcl-x, Bcl-2 and Bcl-w, are synthesised in mouse mammary gland, and dynamic changes in the expression profiles of these proteins occurs during development. To determine if changes in Bak and Bcl-w expression could regulate mammary apoptosis, their effect on cultured mouse mammary epithelial cells was examined in transient transfection assays. Enforced expression of Bak induced rapid mammary apoptosis, which could be suppressed by coexpression of Bcl-w. In extracts of mammary tissue in vivo, Bak heterodimerized with Bcl-x whereas Bax associated with Bcl-w, but Bak/Bcl-w heterodimers were not detected. Thus, Bak and Bcl-w may regulate cell death through independent pathways. These results support a model in which mammary epithelial cells are primed for apoptosis during the transition from pregnancy to lactation by de novo expression of the death effectors Bak and Bad. It is suggested that these proteins are prevented from triggering apoptosis by anti-apoptotic Bcl-2 family proteins until involution, when the levels of Bcl-w decline. Our study provides evidence that regulated changes in the expression of cell death genes may contribute to the developmental control of mammary apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318769      PMCID: PMC3049815          DOI: 10.1242/jcs.112.11.1771

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  46 in total

1.  Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

Authors:  C Teixeira; J C Reed; M A Pratt
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

2.  Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K.

Authors:  S N Farrow; J H White; I Martinou; T Raven; K T Pun; C J Grinham; J C Martinou; R Brown
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

3.  Bax-independent inhibition of apoptosis by Bcl-XL.

Authors:  E H Cheng; B Levine; L H Boise; C B Thompson; J M Hardwick
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

4.  bcl-w, a novel member of the bcl-2 family, promotes cell survival.

Authors:  L Gibson; S P Holmgreen; D C Huang; O Bernard; N G Copeland; N A Jenkins; G R Sutherland; E Baker; J M Adams; S Cory
Journal:  Oncogene       Date:  1996-08-15       Impact factor: 9.867

5.  Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland.

Authors:  A C Andres; G Zuercher; V Djonov; M Flueck; A Ziemiecki
Journal:  Int J Cancer       Date:  1995-10-09       Impact factor: 7.396

6.  Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant.

Authors:  C G Print; K L Loveland; L Gibson; T Meehan; A Stylianou; N Wreford; D de Kretser; D Metcalf; F Köntgen; J M Adams; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.

Authors:  S Krajewski; C Blomqvist; K Franssila; M Krajewska; V M Wasenius; E Niskanen; S Nordling; J C Reed
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

8.  Bax-deficient mice with lymphoid hyperplasia and male germ cell death.

Authors:  C M Knudson; K S Tung; W G Tourtellotte; G A Brown; S J Korsmeyer
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

9.  Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland.

Authors:  Z Feng; A Marti; B Jehn; H J Altermatt; G Chicaiza; R Jaggi
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

10.  Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

Authors:  L R Lund; J Rømer; N Thomasset; H Solberg; C Pyke; M J Bissell; K Danø; Z Werb
Journal:  Development       Date:  1996-01       Impact factor: 6.868

View more
  28 in total

1.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 3.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

Review 4.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

Review 5.  Illuminating the center: mechanisms regulating lumen formation and maintenance in mammary morphogenesis.

Authors:  Mauricio J Reginato; Senthil K Muthuswamy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

Review 6.  The molecular culprits underlying precocious mammary gland involution.

Authors:  Kate D Sutherland; Geoffrey J Lindeman; Jane E Visvader
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

7.  BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.

Authors:  Arnaud A Mailleux; Michael Overholtzer; Tobias Schmelzle; Philippe Bouillet; Andreas Strasser; Joan S Brugge
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

8.  SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.

Authors:  Marjan E Askarian-Amiri; Joanna Crawford; Juliet D French; Chanel E Smart; Martin A Smith; Michael B Clark; Kelin Ru; Tim R Mercer; Ella R Thompson; Sunil R Lakhani; Ana C Vargas; Ian G Campbell; Melissa A Brown; Marcel E Dinger; John S Mattick
Journal:  RNA       Date:  2011-04-01       Impact factor: 4.942

Review 9.  Characterizing regeneration in the vertebrate ear.

Authors:  Anthony D Metcalfe; Hayley Willis; Alice Beare; Mark W J Ferguson
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

10.  Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.

Authors:  Mark R Pickard; Andrew R Green; Ian O Ellis; Carlos Caldas; Vanessa L Hedge; Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Breast Cancer Res       Date:  2009-08-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.